Loading clinical trials...
Loading clinical trials...
A Phase II Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Conditions
Interventions
MK2206
Locations
13
France
Institut Bergonié
Bordeaux, France
Centre Henri Mondor
Créteil, France
CHRU
Lille, France
Centre Leon Berard
Lyon, France
Institut Paoli Calmettes
Marseille, France
CHU St Eloi
Montpellier, France
Start Date
November 1, 2011
Primary Completion Date
September 1, 2013
Completion Date
June 1, 2014
Last Updated
July 10, 2014
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Centre Leon Berard
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions